About Celloid
Celloid is a company based in Pohang-si (South Korea) founded in 2021. Celloid has raised $1.8 million across 2 funding rounds from investors including FuturePlay and POSTECH Holdings. Celloid offers products and services including 3D Cell Culture Solution and Automated Culture System. Celloid operates in a competitive market with competitors including Pluri, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others.
- Headquarter Pohang-si, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.8 M (USD)
in 2 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Jan 31, 2024
-
Investors
FuturePlay
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celloid
Celloid offers a comprehensive portfolio of products and services, including 3D Cell Culture Solution and Automated Culture System.
Offers 3D systems for reproducible cell cultures in therapy manufacturing.
Facilitates automated processes for organoid development in research.
Funding Insights of Celloid
Celloid has successfully raised a total of $1.8M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Celloid
Celloid has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include FuturePlay and POSTECH Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
FuturePlay is engaged in startup investment and acceleration.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Celloid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celloid
Investment portfolio details for Celloid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celloid
Detailed financials for Celloid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celloid Comparisons
Peer comparison for Celloid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celloid
Celloid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation cell-based products are developed across multiple industries.
|
|
| Locked | Locked | Locked |
3D cell culture robots are developed for medical research applications.
|
|
| Locked | Locked | Locked |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| Locked | Locked | Locked |
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
|
|
| Locked | Locked | Locked |
Glycan analysis services and kits are offered by S-BIO.
|
Detailed competitors of Celloid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celloid
Complete news archive for Celloid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celloid
Celloid was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Celloid is headquartered in Pohang-si, South Korea. It is registered at Pohang-si, North Gyeongsang Province, South Korea.
Celloid is a funded company, having raised a total of $1.8M across 2 funding rounds to date.
Celloid was founded in 2021 in South Korea. Operations are centered in the biotechnology sector, where 3D cell culture solutions for drug development are supplied. The OrgaNest platform is utilized as the main offering, incorporating highly permeable microwells for high-throughput automated culture. A closed continuous perfusion system is integrated to maintain nutrient flow and waste removal in controlled environments. Services support research and testing processes in pharmaceutical applications.
Celloid's top competitors include Pluri, Mo:re and ExCel Matrix Biological Devices.
Celloid offers 3D Cell Culture Solution and Automated Culture System.
Celloid has 2 investors. Key investors include FuturePlay, and POSTECH Holdings.